Statera Biopharma, Inc. Derivative Liability
Statera Biopharma, Inc. had Derivative Liability of $945.74 thousand as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2021-11-15
- 2021-09-30: Derivative Liability $945.74K.
- 2020-09-30: Derivative Liability $8.61K.
- 2020-06-30: Derivative Liability $275.49K.
- 2020-03-31: Derivative Liability $44.41K.
| Period end | Derivative Liability |
|---|---|
| 2021-09-30 | $945.74K 10-Q · filed 2021-11-15 |
| 2020-09-30 | $8.61K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $275.49K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $44.41K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.41K 10-K · filed 2021-03-22 |
| 2019-09-30 | $24.46K 10-Q · filed 2019-11-14 |
| 2018-12-31 | $78.64K 10-K · filed 2020-04-15 |
| 2014-03-31 | $1.44M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.24M 10-Q · filed 2014-05-12 |
| 2013-09-30 | $3.59M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $4.76M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $4.11M 10-K · filed 2014-03-17 |
| 2012-06-30 | $4.11M 10-Q · filed 2013-08-09 |